Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer in the United States. The company's lead product candidate is zetomipzomib (KZR-616), a selective immunoproteasome inhibitor that is in Phase 2b clinical trials for various indications, including lupus nephritis, dermatomyositis, and polymyositis; Phase 1b clinical trials in systemic lupus erythematosus; and completed Phase 2a clinical trials in lupus nephritis. Its preclinical products include KZR-261, a novel first-in-class protein secretion inhibitor for the treatment of tumors resistant to traditional chemotherapeutics. Kezar Life Sciences, Inc. was incorporated in 2015 and is headquartered in South San Francisco, California.

Kezar Life Sciences Inc.

Kalamazoo Resources Ltd. ( ($AU:KZR) ) has shared an update. Kalamazoo Resources Ltd. has announced a change in the director’s interest, specifical...

Kalamazoo Resources Ltd. Announces Change in Director’s Interest

The latest announcement is out from Kalamazoo Resources Ltd. ( ($AU:KZR) ). Kalamazoo Resources Ltd. announced the cessation of 11 million securiti...

Kalamazoo Resources Ltd. Announces Cessation of Securities

An update from Kalamazoo Resources Ltd. ( ($AU:KZR) ) is now available. Kalamazoo Resources Limited has announced the commencement of a diamond dri...

Kalamazoo Resources Initiates Drilling at Ashburton Gold Project

Kalamazoo Resources Ltd. ( ($AU:KZR) ) has issued an announcement. Kalamazoo Resources Ltd. announced the cessation of 1,875,000 performance rights...

Kalamazoo Resources Announces Cessation of Securities

MacKenzie Realty Capital, Inc. ( ($MKZR) ) has issued an update. On November 18, 2025, MacKenzie Realty Capital reported its financial results for ...

MacKenzie Realty Capital Reports Q1 2025 Financial Results

An announcement from Kalamazoo Resources Ltd. ( ($AU:KZR) ) is now available. Kalamazoo Resources Limited, a company listed on the ASX, has announc...

Kalamazoo Resources Director Acquires Shares, Signaling Confidence

Kalamazoo Resources Ltd. ( ($AU:KZR) ) has shared an update. Kalamazoo Resources Limited has announced the quotation of 150,000 ordinary fully paid...

Market Cap	$45.77M	P/E Ratio	N/A
52W High	$6.95	52W Low	$3.53
Div Yield	N/A	Payout Ratio	N/A
EPS Growth 3Y	-3.4%	52W Position	79.2%
Overall Score	50	Value Score	60
Quality Score	28	Technical Score	63

EPS Current Est	$-7.03	EPS Next Est	$-2.97
EPS Growth Est	N/A	DPS Growth 3Y	N/A

	A	B	C	D
1	Symbol	Price	Change	Volume
2	KZR	$6.24	-0.95%	41.52K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	KZR	$6.24	-1.0%	41.52K
3
4
5
6

KZR

KZR

Key Metrics Overview

Growth Analysis

Revenue (5Y)

EBITDA (5Y)

Get Kezar Life Sciences Inc. Data in Excel

Get Kezar Life Sciences Inc. Data in Excel